Genomic Analysis of Circulating Cells: A Window Into Atherosclerosis

Trends in Cardiovascular Medicine

Volumn 16, Issue 5, 2006, Pages 163-168

  Kang, Ju Gyeong ^a   Patino, Willmar D ^a   Matoba, Satoaki ^a   Hwang, Paul M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA;

ARTERY OCCLUSION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ENDARTERECTOMY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; INFLAMMATION; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEOMICS; REVIEW; VALIDATION STUDY;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; MONOCYTES; RIBOSOMAL PROTEINS; RNA, MESSENGER; VASCULITIS;

EID: 33744974763     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.03.006     Document Type: Review

References (41)

1. Borovecki F., Lovrecic L., Zhou J., et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 102 (2005) 11023-11028
2. Cahan P., Ahmad A., Burke H., et al. List of Lists-Annotated (LOLA): a database for annotation and comparison of published microarray gene lists. Gene 360 (2005) 78-82
3. Chapman C., Beilby J., McQuillan B., et al. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 35 (2004) 1619-1624
4. Cipolletta C., Ryan K., Hanna E., and Trimble E. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes 54 (2005) 2779-2786
5. Cook S., and Rosenzweig A. DNA microarrays: implications for cardiovascular medicine. Circ Res 91 (2002) 559-564
6. Daugherty A., and Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med 14 (2004) 117-120
7. Ebert B., and Golub T. Genomic approaches to hematologic malignancies. Blood 104 (2004) 923-932
8. Farooq A., and Zhou M. Structure and regulation of MAPK phosphatases. Cell Signal 16 (2004) 769-779
9. Fryer R., Randall J., Yoshida T., et al. Global analysis of gene expression: methods, interpretation, and pitfalls. Exp Nephrol 10 (2002) 64-74
10. Fukuda D., Shimada K., Tanaka A., et al. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 43 (2004) 18-23
11. Ganesh S., Skelding K., Mehta L., et al. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. Pharmacogenomics 5 (2004) 952-1004
12. Glass C., and Witztum J. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
13. Gui M., Fan H., Steplewski K., Carpenter J., et al. Gene expression profiling of peripheral blood mononuclear cells in humans yields potential biomarkers of accelerated atherosclerotic disease that are independent of known cardiovascular risk factors. Circulation 110 Suppl S (2004) 1309
14. Hakonarson H., Bjornsdottir U., Halapi E., et al. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc Natl Acad Sci U S A 102 (2005) 14789-14794
15. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
16. Harbers M., and Carninci P. Tag-based approaches for transcriptome research and genome annotation. Nat Methods 2 (2005) 495-502
17. Hashimoto S., Suzuki T., Dong H., et al. Serial analysis of gene expression in human monocytes and macrophages. Blood 94 (1999) 837-844
18. Horwitz P., Tsai E., Putt M., et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110 (2004) 3815-3821
19. Hwang J., Allen P., Tseng G., et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10 (2002) 31-44
20. Jain M., and Ridker P. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 4 (2005) 977-987
21. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
22. Liu Y., Dvornyk V., Lu Y., et al. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem 280 (2005) 29011-29016
23. Lowes B., Gilbert E., Abraham W., et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 346 (2002) 1357-1365
24. Lusis A. Atherosclerosis. Nature 407 (2000) 233-241
25. Maekawa Y., Anzai T., Yoshikawa T., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 39 (2002) 241-246
26. McCaffrey T., Fu C., Du B., et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest 105 (2000) 653-662
27. Moore D., Li H., Jeffries N., Wright V., et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 111 (2005) 212-221
28. Newman J., and Weiner A. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol 6 (2005) R81
29. Olsen N., Moore J., and Aune T. Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells. Arthritis Res Ther 6 (2004) 120-128
30. Patino W., Mian O., and Hwang P. Serial analysis of gene expression: technical considerations and applications to cardiovascular biology. Circ Res 91 (2002) 565-569
31. Patino W., Mian O., Kang J., et al. Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci U S A 102 (2005) 3423-3428
32. Polyak K., and Riggins G. Gene discovery using the serial analysis of gene expression technique: implications for cancer research. J Clin Oncol 19 (2001) 2948-2958
33. Ridker P., Cannon C., Morrow D., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
34. Rossi M., Marziliano N., Merlini P., et al. Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromes. Circulation 110 (2004) 1767-1773
35. Seo D., Wang T., Dressman H., et al. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 1922-1927
36. Sharma P., Sahni N., Tibshirani R., et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res. 7 (2005) R634-R644
37. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 4 (2002) E131-E136
38. Tabibiazar R., Wagner R., Ashley E., et al. Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol Genomics 22 (2005) 213-226
39. van de Vijver M., He Y., van't Veer L., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
40. Vanderlaan P., and Reardon C. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 46 (2005) 829-838
41. Wibaut-Berlaimont V., Randi A., Mandryko V., et al. Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis. J Thromb Haemost 3 (2005) 677-685